HCV-infected dialysis patients: History is changing

被引：0
|
作者：
Parlati, Lucia [1 ]
Pol, Stanislas [2 ]
机构：
[1] Univ Paris 05, Cochin Hosp, AP HP, Hepatol Dept,UPMC, F-75014 Paris, France
[2] Univ Paris 05, Cochin Hosp, AP HP,Inst Pasteur, Hepatol Dept,Inserm U1223,UMS 20,Ctr Translat Sci, F-75014 Paris, France
来源：
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY | 2019年 / 43卷 / 03期
关键词：
HEPATITIS-C; PREVALENCE; RISK;
D O I：
10.1016/j.clinre.2018.12.006
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：225 / 227
页数：3
相关论文
共 50 条
  • [21] EMPIRICAL CALIBRATION OF HEPATITIS C VIRUS (HCV) NATURAL HISTORY MODEL TO THE CHINESE HCV-INFECTED POPULATION
    Lee, K.
    VALUE IN HEALTH, 2016, 19 (07) : A850 - A850
  • [22] Renal transplantation offers a better survival in HCV-infected ESRD patients
    Sezer, S
    Ozdemir, FN
    Akcay, A
    Arat, Z
    Boyacioglu, S
    Haberal, M
    CLINICAL TRANSPLANTATION, 2004, 18 (05) : 619 - 623
  • [23] THROMBOSPONDIN 2 LEVELS REFLECT DISEASE ACTIVITY IN HCV-INFECTED PATIENTS
    Kimura, Takefumi
    Iwadare, Takanobu
    Umemura, Takeji
    GASTROENTEROLOGY, 2023, 164 (06) : S1367 - S1367
  • [24] Hepatitis C virus quantification in serum and saliva of HCV-infected patients
    Lopes Menezes, Gisele Barreto
    Pereira, Fernanda Albuquerque
    Barros Duarte, Cesar Augusto
    Azevedo Carmo, Theomira Mauadie
    da Silva Filho, Hermes Pedreira
    Zarife, Maria Alice
    Krieger, Marco Aurelio
    Gomes Reis, Eliana Almeida
    Reis, Mitermayer G.
    MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2012, 107 (05): : 680 - 683
  • [25] Protease inhibitors impair renal function in HCV-infected immunocompetent patients
    Fernandez-Carrillo, Carlos
    Manuel Pascasio, Juan
    Prieto, Martin
    Montero, J. L.
    Crespo, Javier
    Fernandez, Inmaculada
    Forns, Xavier
    Garcia-Samaniego, Javier
    Romero-Gomez, Manuel
    Turnes, Juan
    Javier Moreno, J.
    Llop, Elba
    Serrano-Millan, Cristina
    Buti, Maria
    Luis Calleja, Jose
    HEPATOLOGY, 2014, 60 : 679A - 679A
  • [26] Prevalence of cryoglobulinemia and cryoglobulinemic vasculitis in chronically HCV-infected Brazilian patients
    Freitas-de Aguiar, Mariana
    Faria-Janes, Anna L.
    Garcia-Brandes, Gabriela, I
    Takemi-Emori, Christini
    Gomes-Ferraz, Maria L.
    Coelho-Andrade, Luis E.
    Silva-de Souza, Alexandre W.
    ANNALS OF HEPATOLOGY, 2019, 18 (05) : 685 - 692
  • [27] Risk-taking behavior and impulsivity among HCV-infected patients
    Dantas-Duarte, Adriana
    Morais-de-Jesus, Mychelle
    Nunes, Ana Paula
    Miranda-Pettersen, Karine
    Araujo-de-Freitas, Lucas
    Netto, Liana R.
    Santos, Carlos Teles
    Codes, Liana
    Quarantini, Lucas C.
    PSYCHIATRY RESEARCH, 2016, 243 : 75 - 80
  • [28] Interferon-free treatment for HCV-infected patients with decompensated cirrhosis
    Kanda, Tatsuo
    HEPATOLOGY INTERNATIONAL, 2017, 11 (01) : 38 - 44
  • [29] Altered Thymic Function during Interferon Therapy in HCV-Infected Patients
    Beq, Stephanie
    Rozlan, Sandra
    Pelletier, Sandy
    Willems, Bernard
    Bruneau, Julie
    Lelievre, Jean-Daniel
    Levy, Yves
    Shoukry, Naglaa H.
    Cheynier, Remi
    PLOS ONE, 2012, 7 (04):
  • [30] Statin Utilization as a Function of Calculated ASCVD Risk in HCV-Infected Patients
    Goble, Spencer
    Nyembo, Philippe
    Goodroad, Brian
    Konstantinides, George
    Noska, Amanda J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S901 - S902
12345